Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs

Interactive Cardiovascular and Thoracic Surgery

Volumn 5, Issue 1, 2006, Pages 47-51

  Ayed, Adel K ^a   Adesina, Aaron ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

Cyclin D1 expression; Non small cell lung cancer; Prognostic factor

Indexed keywords

CYCLIN D1;

ADULT; ARAB; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 32044444066     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2005.120030     Document Type: Article

References (15)

1. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75:191-202.
2. Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci 2004;95:197-204.
3. Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldia F, Wolner E, Giordano A. Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol 1999;20:746-750.
4. Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res 2005;11:232-241.
5. Nguyen VN, Mirejovski P, Mirejovsky T, Melinova L, Mandys V. Expression of cyclin D1, ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2. Acta Histochem 2000;102:323-338.
6. Travis WD, Corrin B, Shimosato Y, Brambilla E. The histological typing of lung and pleural tumors. WHO/IASLC classification of lung and pleural tumors. Berlin: Springer-Verlag; 1999.
7. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. NHLB1/WHO Summary. Am J Respir Crit Care Med 2001;163:1256-1276.
9. Cordon-Carlo C. Mutation of cell cycle regulators. Am J Pathol 1995;147:1-16.
10. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WDJ, Cerny T, Thatcher N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996;73:294-300.
11. Mate JL, Ariza A, Aracil C, Lopez D, Ismat M, Perez-Piteira P, Navas-Palacios J. Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol 1996;180:395-399.
12. Mishina T, Dosaka-Akita H, Hommura F, Morikawa T, Katoh H, Kawakami Y. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer 1999;80:1289-1295.
13. Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T, Takahashi T. Prognostic significance of Cyclin D1 and retinoplastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 1997;3:1051-1058.
14. Ratschiller D, Heishway J, Gugger M, Kappeler A, Pirnia F, Schmid RA, Borner MM, Betticher DC. Association of cyclin D1 expression in lung cancer and smoking habits of patients. Cancer Lett 1999;141:147-150.
15. Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Jaskiewics K, Czestochowska E. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer(NSCLC). J Cancer Res Clin Oncol 2005;131:479-485.